- Home
- ALLO vs KRO Comparison
ALLO vs KRO Comparison
Compare ALLO & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | KRO |
|---|---|---|
| Founded | 2017 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 760.5M |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ALLO | KRO |
|---|---|---|
| Price | $2.06 | $6.57 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 15 | 2 |
| Target Price | ★ $8.35 | $6.00 |
| AVG Volume (30 Days) | ★ 7.8M | 249.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.79% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,859,400,000.00 |
| Revenue This Year | N/A | $6.75 |
| Revenue Next Year | $142,416.42 | $8.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $4.08 |
| 52 Week High | $4.46 | $7.89 |
Technical Indicators
Market Signals| Indicator | ALLO | KRO |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 43.04 |
| Support Level | $1.85 | $6.58 |
| Resistance Level | $2.36 | $6.80 |
| Average True Range (ATR) | 0.13 | 0.31 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 74.12 | 17.08 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.